Richard R. Kerr
Vitamin D, prostate Ca: Study points to missing link
Inflammation may be the missing link between vitamin D and prostate cancer, new study findings from the University of Colorado Cancer Center in Denver suggest.
Diet and male fertility: What helps, what hurts
Papers examining the effects of diet and substance use on male fertility presented at the recently concluded American Society for Reproductive Medicine annual meeting in Honolulu may appear to provide conflicting findings, but an expert in andrology says the observational studies don’t tell the complete story.
Prostate cancer test granted draft Medicare LCD
Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Prolaris prostate cancer test, Myriad Genetics, Inc. announced.
AUA appoints new Office of Education chair
Victor W. Nitti, MD, has been appointed by the AUA Board of Directors as the new Chair of the AUA Office of Education.
Study: PCa test identifies tumor aggressiveness
New study data confirm the ability of the ConfirmMDx genes to identify prostate cancer aggressiveness in diagnostic biopsies, researchers reported.
AUA checklist a resource for common men’s health issues
The AUA’s Committee on Male Health has developed a checklist to serve as a resource of urologic and non-urologic men’s health considerations. Intended for urologists and other health care providers, it is also aimed at better coordinating care among men’s providers.
‘Men’s health’ more than a marketing ploy
Urology Times is committed to the men’s health trend and to helping you make the most of it, UT Group Content Director Richard R. Kerr writes.
MMC injections may end cycle of contracture Tx failures
In patients with recurrent bladder neck contractures, history often repeats itself with multiple surgeries and poor outcomes, but reconstructive urologists are now hopeful they have a better solution.
Medicare to cover one PCa test, PPO covers another
The ConfirmMDx for Prostate Cancer test qualifies for Medicare coverage effective Nov. 3, 2014, MDxHealth SA announced, while the maker of a second test, the Decipher Prostate Cancer Classifier, has added a new preferred provider organization to expand coverage of that test.
FDA panel’s vote on TRT draws reaction from urologists
FDA panel’s vote on TRT draws reaction from urologists
An FDA advisory committee has voted to restrict indications for testosterone replacement therapy and require additional clinical trials to test the safety of the drugs, decisions that have drawn mixed reactions from urologists.

Poll